Edition:
United States

People: Inovio Pharmaceuticals Inc (INO.O)

INO.O on Nasdaq

2.37USD
16 Aug 2019
Change (% chg)

$0.18 (+8.22%)
Prev Close
$2.19
Open
$2.22
Day's High
$2.39
Day's Low
$2.21
Volume
506,449
Avg. Vol
952,381
52-wk High
$6.30
52-wk Low
$2.15

Kies, Peter 

Mr. Peter D. Kies is the Chief Financial Officer of Inovio Pharmaceuticals Inc., since June 2002. Mr. Kies has been employed as our Chief Financial Officer since 2002. From 1996 until joining us, he served as Chief Financial Officer for Newgen Results Corporation, and prior to that served as Controller for Cytel Corporation and as an auditor for Ernst & Young LLP. Mr. Kies holds a B.S. in Business Administration from United States International University in San Diego, California.

Basic Compensation

Total Annual Compensation, USD 608,207
Restricted Stock Awards, USD 354,783
Long-Term Incentive Plans, USD --
All Other, USD 368,622
Fiscal Year Total, USD 1,331,610

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 25,001 35,759.00
Name Fiscal Year Total

Simon Benito

151,301

Jong Kim

3,081,040

Peter Kies

1,331,610

Jacqueline Shea

--

Laurent Humeau

--

David Weiner

447,636
As Of  30 Dec 2018